Published in J Biol Chem on November 17, 1995
A comprehensive map of the toll-like receptor signaling network. Mol Syst Biol (2006) 2.89
Nanoparticles activate the NLR pyrin domain containing 3 (Nlrp3) inflammasome and cause pulmonary inflammation through release of IL-1α and IL-1β. Proc Natl Acad Sci U S A (2010) 2.09
Sequential DNA damage-independent and -dependent activation of NF-kappaB by UV. EMBO J (1998) 1.55
A potential therapeutic role for P2X7 receptor (P2X7R) antagonists in the treatment of inflammatory diseases. Expert Opin Investig Drugs (2011) 1.39
The enigmatic processing and secretion of interleukin-33. Cell Mol Immunol (2010) 1.32
The role of the inflammasome in nonmyeloid cells. J Clin Immunol (2010) 1.18
Interleukin 1α and the inflammatory process. Nat Immunol (2016) 0.96
The dynamics and mechanisms of interleukin-1alpha and beta nuclear import. Traffic (2008) 0.92
Is the inflammasome a potential therapeutic target in renal disease? BMC Nephrol (2014) 0.92
HMGB1, IL-1α, IL-33 and S100 proteins: dual-function alarmins. Cell Mol Immunol (2016) 0.89
Vinpocetine inhibits amyloid-beta induced activation of NF-κB, NLRP3 inflammasome and cytokine production in retinal pigment epithelial cells. Exp Eye Res (2014) 0.89
Interleukin-1α mediates the antiproliferative effects of 1,25-dihydroxyvitamin D3 in prostate progenitor/stem cells. Cancer Res (2011) 0.89
Clash of the Cytokine Titans: counter-regulation of interleukin-1 and type I interferon-mediated inflammatory responses. Cell Mol Immunol (2016) 0.83
Characterisation and expression analysis of the Atlantic halibut (Hippoglossus hippoglossus L.) cytokines: IL-1β, IL-6, IL-11, IL-12β and IFNγ. Mol Biol Rep (2011) 0.79
A combined omics study on activated macrophages--enhanced role of STATs in apoptosis, immunity and lipid metabolism. Bioinformatics (2013) 0.79
Nicotinic acetylcholine receptor α1 promotes calpain-1 activation and macrophage inflammation in hypercholesterolemic nephropathy. Lab Invest (2010) 0.78
Caspase-1-independent interleukin-1β is required for clearance of Bordetella pertussis infections and whole-cell vaccine-mediated immunity. PLoS One (2014) 0.77
Contextualization procedure and modeling of monocyte specific TLR signaling. PLoS One (2012) 0.77
Interleukin-1α Induction in Human Keratinocytes (HaCaT): An In Vitro Model for Chemoprevention in Skin. J Skin Cancer (2012) 0.77
Cloning and expression of murine interleukin-1 cDNA in Escherichia coli. Nature (1985) 9.81
Interleukin 1, a potential regulator of fibroblast proliferation. J Immunol (1982) 6.05
Growth of a cloned helper T cell line induced by a monoclonal antibody specific for the antigen receptor: interleukin 1 is required for the expression of receptors for interleukin 2. J Immunol (1984) 5.51
Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes. J Immunol (1978) 5.36
Interleukin 1 and T cell activation. Immunol Rev (1982) 5.00
Stimulation of rheumatoid synovial cell collagenase and prostaglandin production by partially purified lymphocyte-activating factor (interleukin 1). Proc Natl Acad Sci U S A (1981) 4.89
In vitro activation and nuclear translocation of NF-kappa B catalyzed by cyclic AMP-dependent protein kinase and protein kinase C. Mol Cell Biol (1989) 3.87
Identification of a membrane-associated interleukin 1 in macrophages. Proc Natl Acad Sci U S A (1985) 3.39
Purification to apparent homogeneity of murine interleukin 1. J Immunol (1981) 3.33
Induction of interleukin 2 messenger RNA inhibited by cyclosporin A. Science (1984) 3.17
Interaction of drugs with microtubule proteins. Fed Proc (1974) 3.14
Pretranslational modulation of acute phase hepatic protein synthesis by murine recombinant interleukin 1 (IL-1) and purified human IL-1. J Exp Med (1985) 2.84
Nucleoside transport in mammalian cells. Inhibition by colchicine. Biochemistry (1972) 2.70
The role of macrophages in the acute-phase response: SAA inducer is closely related to lymphocyte activating factor and endogenous pyrogen. Cell Immunol (1981) 2.60
T-Cell lymphoma model for the analysis of interleukin 1-mediated T-cell activation. Proc Natl Acad Sci U S A (1981) 2.51
How does interleukin 1 activate cells? Cyclic AMP and interleukin 1 signal transduction. Immunol Today (1990) 2.48
Interleukin 1 and cyclic AMP induce kappa immunoglobulin light-chain expression via activation of an NF-kappa B-like DNA-binding protein. Mol Cell Biol (1989) 2.28
Studies on the purification and structure-functional relationships of murine lymphocyte activating factor (Interleukin 1). Mol Immunol (1980) 2.28
Signal requirements for T lymphocyte activation. I. Replacement of macrophage function with phorbol myristic acetate. J Immunol (1979) 2.27
In vivo inflammatory activity of epidermal cell-derived thymocyte activating factor and recombinant interleukin 1 in the mouse. J Clin Invest (1986) 2.22
Interleukin 1 alpha and interleukin 1 beta bind to the same receptor on T cells. J Immunol (1986) 2.14
Inhibition of the transport of several hexoses in mammalian cells by cytochalasin B. J Biol Chem (1972) 2.05
Macrophage-independent activation of helper T cells. I. Production of Interleukin 2. J Immunol (1980) 1.96
The participation of macrophages and macrophage cell lines in the activation of T lymphocytes by mitogens. Immunol Rev (1978) 1.94
Studies on the role of lymphocyte-activating factor (Interleukin 1) in antigen-induced lymph node lymphocyte proliferation. Cell Immunol (1980) 1.92
Characterization of lymphocyte-activating factor (LAF) produced by a macrophage cell line, P388D1. II. Biochemical characterization of LAF induced by activated T cells and LPS. J Immunol (1978) 1.92
Immunoregulatory molecules and IL 2 receptors identified in multiple sclerosis brain. J Immunol (1986) 1.87
Studies on the synthesis and secretion of interleukin 1. I. A 33,000 molecular weight precursor for interleukin 1. J Immunol (1985) 1.86
Phorbol myristic acetate stimulates LAF production by the macrophage cell line, P388D. Cell Immunol (1978) 1.86
Physicochemical characterization of lymphocyte-activating factor (LAF). J Immunol (1979) 1.76
Salmonella flagellin induces tumor necrosis factor alpha in a human promonocytic cell line. Infect Immun (1998) 1.72
Participation of lymphocyte activating factor (Interleukin 1) in the induction of cytotoxic T cell responses. J Immunol (1980) 1.72
High-affinity interaction between gram-negative flagellin and a cell surface polypeptide results in human monocyte activation. Infect Immun (2000) 1.70
Role of interleukin 1 in anti-immunoglobulin-induced B cell proliferation. J Exp Med (1983) 1.69
Regulation of class III major histocompatibility complex gene products by interleukin-1. Science (1986) 1.65
Preparation of goat antibodies against interleukin 1: use of an immunoadsorbent to purify interleukin 1. J Immunol (1983) 1.57
Expression of interleukin-1 alpha and beta genes by human blood polymorphonuclear leukocytes. J Clin Invest (1991) 1.54
The interleukin 1 receptor. Dynamics of interleukin 1 binding and internalization in T cells and fibroblasts. J Immunol (1987) 1.49
Cyclic AMP--an intracellular second messenger for interleukin 1. Proc Natl Acad Sci U S A (1988) 1.45
Revised nomenclature for antigen-nonspecific T-cell proliferation and helper factors. Cell Immunol (1979) 1.44
Characterization of lymphocyte-activating factor (LAF) produced by human mononuclear cells: biochemical relationship of high and low molecular weight forms of LAF. J Immunol (1979) 1.38
Interleukin 1-mediated induction of kappa-light chain synthesis and surface immunoglobulin expression on pre-B cells. J Immunol (1984) 1.34
Involvement of a calpain-like protease in the processing of the murine interleukin 1 alpha precursor. J Biol Chem (1991) 1.24
Induction of cytokine synthesis by flagella from gram-negative bacteria may be dependent on the activation or differentiation state of human monocytes. Infect Immun (1999) 1.21
Characterization of the human interleukin 1 receptor on human polymorphonuclear leukocytes. Clin Immunol Immunopathol (1988) 1.20
Regulation of lymphocyte-activating factor (LAF) production and secretion in P388D1 cells: identification of high molecular weight precursors of LAF. J Immunol (1979) 1.19
Salmonellae activate tumor necrosis factor alpha production in a human promonocytic cell line via a released polypeptide. Infect Immun (1997) 1.09
Stimulation of fibroblast proliferation and prostaglandin production by purified recombinant murine interleukin 1. Clin Immunol Immunopathol (1986) 1.09
In vitro T cell-mediated killing of Pseudomonas aeruginosa. II. The role of macrophages and T cell subsets in T cell killing. J Immunol (1985) 1.05
Induction of interleukin 2 responsiveness in thymocytes by synergistic action of interleukin 1 and interleukin 2. J Immunol (1985) 1.05
IL-1 secretion by macrophages. Enhancement of IL-1 secretion and processing by calcium ionophores. J Immunol (1990) 1.04
Differential effect of cytochalasin B on the two possible modes of 2-deoxyglucose transport in HeLa cells. Nat New Biol (1973) 1.03
Activation of interleukin-1 receptor-associated kinase by gram-negative flagellin. Infect Immun (2001) 1.03
Regulation of lipoprotein lipase synthesis and 3T3-L1 adipocyte metabolism by recombinant interleukin 1. Biochim Biophys Acta (1986) 1.02
I-A-positive nonlymphoid cells and T cell development in murine fetal thymus organ cultures: interleukin 1 circumvents the block in T cell differentiation induced by monoclonal anti-I-A antibodies. J Immunol (1986) 1.01
Interleukin-1 beta secretion. A possible multistep process that is regulated in a cell type-specific manner. J Biol Chem (1995) 0.99
Detection of IL-1 alpha and IL-1 beta in the supernatants of paraformaldehyde-treated human monocytes. Evidence against a membrane form of IL-1. J Immunol (1990) 0.95
Signal transduction pathway for IL-1. Involvement of a pertussis toxin-sensitive GTP-binding protein in the activation of adenylate cyclase. J Immunol (1989) 0.94
Involvement of cyclic AMP-dependent protein kinases in the signal transduction pathway for interleukin-1. Mol Cell Biol (1990) 0.93
Down-regulation of interleukin 1 production by macrophages of sarcoma-bearing mice. J Immunol (1987) 0.93
Activation of AP-1 by IL-1 and phorbol esters in T cells. Role of protein kinase A and protein phosphatases. J Immunol (1991) 0.90
mRNA and protein stability regulate the differential expression of pro- and anti-inflammatory genes in endotoxin-tolerant THP-1 cells. J Biol Chem (2000) 0.89
Characterization of the structural requirements and cell type specificity of IL-1 alpha and IL-1 beta secretion. J Biol Chem (1993) 0.88
Disparate functional properties of two interleukin 1-responsive Ly-1+2- T cell clones: distinction of T cell growth factor and T cell-replacing factor activities. J Immunol (1983) 0.86
Generation of human peripheral blood stable E-rosette-forming T cells by interleukin 1. Clin Immunol Immunopathol (1981) 0.86
Structure-function analysis of murine interleukin 1: biologically active polypeptides are at least 127 amino acids long and are derived from the carboxyl terminus of a 270-amino acid precursor. Proc Natl Acad Sci U S A (1986) 0.86
Biochemical and biological characterization of lymphocyte-activating factor (LAF) produced by the murine macrophage cell line, P388D. Ann N Y Acad Sci (1979) 0.86
Studies on the action of nerve growth factor. I. Characterization of a simplified in vitro culture system for dorsal root and sympathetic ganglia. Dev Biol (1976) 0.85
Evidence against the existence of a membrane form of murine IL-1 alpha. J Immunol (1989) 0.84
IL 1 requirement for B cell activation revealed by use of adult serum. J Immunol (1984) 0.83
In vitro production of immunosuppressive factors by murine sarcoma virus-transformed mouse fibroblasts. Proc Natl Acad Sci U S A (1980) 0.80
Proteasome-mediated regulation of interleukin-1beta turnover and export in human monocytes. J Leukoc Biol (2000) 0.80
Interleukin-1 signal transduction. Eur Cytokine Netw (1995) 0.79
Murine interleukin 1. Methods Enzymol (1985) 0.79
Molecular signals in antigen presentation. I. Effects of interleukin 1 and 2 on radiation-treated antigen-presenting cells in vivo and in vitro. Clin Immunol Immunopathol (1983) 0.79
Molecular signals in antigen presentation. II. Activation of cytolytic cells in vitro after ultraviolet radiation or combined gamma and ultraviolet radiation treatment of antigen-presenting cells. J Immunol (1984) 0.79
Studies on the action of nerve growth factor. II. Neurotubule protein levels during neurite outgrowth. Neurobiology (1975) 0.79
Induction of AP-1 transcription factor components during T-cell activation by interleukin 1 and phorbol esters. Cell Growth Differ (1992) 0.78
The role of IL 1 in the antigen-specific activation of murine class II-restricted T lymphocyte clones. J Immunol (1985) 0.78
Studies on the action of nerve growth factor. III. Role of RNA and protein synthesis in the process of neurite outgrowth. Dev Biol (1976) 0.77
Interleukin 1 activation of the AP-1 transcription complex in murine T cells is regulated at the level of Jun B protein accumulation. Mol Immunol (1995) 0.76
Characterization of murine T cell activation signals produced by B lymphoma cells. J Immunol (1985) 0.75
Partial purification of an immunosuppressive protein from a human tumor cell line and analysis of its relationship to transforming growth factor beta. Cell Immunol (1989) 0.75